-
IndusInd Bank
708.45 1,576.00(%) -
Kalyan Jewellers
519.15 794.60(%) -
Dr Lal Pathlabs
2,508.00 3,645.00(%) -
ICICI BLR Growth
1,003.14 1,001.47(%) -
Vodafone Idea
8.33 19.15(%) -
Bharat Electron
274.50 204.00(%) -
Quadrant Future
605.00 743.45(%) -
Zomato Ltd
212.60 304.50(%) -
SRF
2,986.25 3,074.95(%) -
Bengal & Assam
7,450.00 11,498.90(%) -
ICICI Bank
1,338.00 1,372.50(%) -
Mazagon Dock
2,610.00 2,929.98(%) -
Suzlon Energy
57.74 86.04(%) -
SpiceJet
46.10 79.90(%) -
Dixon Technolog.
13,485.00 19,149.80(%) -
Adani Green
944.95 2,173.65(%) -
Aegis Logistics
830.35 1,035.70(%) -
Hind.Aeronautics
4,252.00 5,675.00(%) -
M & M
2,660.50 3,276.30(%) -
Nippon ETF Liq.
999.99 996.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Dr Lal Pathlabs Ltd Healthcare
- Indian Private
- BSE Code : 41261.0
- ISIN : INE600L01024
-
Today’s Low
2,376.10 -
Today’s High
2,519.00

-
Open
2,489.75 -
Perv Close
2,478.80 -
52W Low
2,165.80 -
52W High
3,653.95
Key Indicators
-
P/E(TTM)
43.47
-
Mar.Cap (₹Cr.)
20,057.00
-
Div & Yield %
0.75
-
Book Value(₹)
248.15
-
Debt-Equity Ratio
-3.20
-
AGM Date
01-Apr-2025
-
EPS
55.28
-
P/E Ratio
43.47
Financials Ratios
-
Debt-Equity Ratio
0.19
-
Mar.Cap (₹Cr.)
20,057.00
-
RONW (%)
20.61
-
ROCE (%)
25.58
Score Board
-
Equity (₹ in Cr.)
83.59
-
BV (₹)
248.10
-
Sales( ₹ in Cr.)
1,966.76
-
NP (in Cr.)
384.13
-
NP Var(%)
32.0
-
Div%
180.0
-
CPS (₹)
55.10
-
EPS (₹)
46.00
-
Traded Value (₹ in Lakhs)
20,089.18
-
52 Week High
3,653.95
-
52 Week Low
2,165.80
-
Price BSE
2403.0
-
Price NSE
2,399.00
-
Market Capital( in Cr.)
20,089.18
-
P/C Ratio
43.60
-
P/E Ratio
52.30
-
Price Vs.BV
46.00
-
25-Feb-2025( 03:00)
Hot Pursuit - Dr La... - <p>Aditya Birla Real Estate Lt...
-
18-Feb-2025( 06:20)
Corporate News - Dr La... - Dr Lal Pathlabs has allotted 4...
-
30-Jan-2025( 02:39)
Results - Announcements - Dr La... - Net profit of Dr Lal Pathlabs...
-
30-Jan-2025( 02:09)
Corporate News - Board... - Dr. Lal PathLabs announced tha...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|---|---|
Sales Turnover | 1,966.76 | 1,769.03 | 1,878.79 | 1,490.56 | 1,273.60 | 1,164.90 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 1,966.76 | 1,769.03 | 1,878.79 | 1,490.56 | 1,273.60 | 1,164.90 |
Other Income | 60.11 | 46.60 | 53.10 | 51.27 | 57.61 | 46.49 |
Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Income | 2,026.86 | 1,815.63 | 1,931.89 | 1,541.82 | 1,331.21 | 1,211.39 |
EXPENDITURE : | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Employee Cost | 363.59 | 315.50 | 321.44 | 257.44 | 232.07 | 201.86 |
Other Manufacturing Expenses | 45.93 | 41.17 | 45.16 | 38.18 | 37.20 | 37.47 |
Selling & Administrative Expenses | 230.92 | 217.87 | 215.69 | 169.70 | 177.25 | 200.32 |
Miscellaneous Expenses | 45.93 | 41.17 | 45.16 | 38.18 | 37.20 | 37.47 |
Less : Pre-operative Expenses Capitalised : | ||||||
Total Expenditure | 1,510.89 | 1,424.80 | 1,470.90 | 1,167.78 | 1,028.46 | 919.03 |
Operating Profit | 376.33 | 344.15 | 336.38 | 243.96 | 212.40 | 187.49 |
Interest | 26.84 | 34.38 | 28.63 | 14.83 | 14.66 | 0.74 |
Gross Profit | 515.97 | 390.83 | 460.99 | 374.04 | 302.75 | 292.37 |
Depreciation | 76.54 | 82.09 | 75.94 | 69.78 | 68.01 | 36.18 |
Profit Before Tax | 515.97 | 390.83 | 460.99 | 374.04 | 302.75 | 292.37 |
Tax | 137.58 | 101.44 | 118.42 | 98.43 | 84.71 | 104.36 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -5.98 | -2.97 | -2.68 | -4.49 | -11.26 | -5.33 |
Reported Net Profit | 384.37 | 292.36 | 345.25 | 280.11 | 223.18 | 195.44 |
Extraordinary Items | 515.97 | 390.83 | 460.99 | 374.04 | 302.75 | 292.37 |
Adjusted Net Profit | 384.37 | 292.36 | 345.25 | 280.11 | 223.18 | 195.44 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance brought forward | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Statutory Appropriations | 150.26 | 50.02 | 100.01 | 166.69 | 98.93 | 49.76 |
P & L Balance carried down | 384.37 | 292.36 | 345.25 | 280.11 | 223.18 | 195.44 |
Dividend | - | - | - | - | - | - |
Preference Dividend | - | - | - | - | - | - |
Equity Dividend (%) | 180.00 | 60.00 | 120.00 | 200.00 | 120.00 | 60.00 |
Dividend Per Share(Rs) | 18.00 | 6.00 | 12.00 | 20.00 | 12.00 | 6.00 |
Earnings Per Share-Unit Curr | 46.25 | 35.28 | 41.75 | 33.61 | 27.09 | 23.74 |
Book Value | 150.26 | 50.02 | 100.01 | 166.69 | 98.93 | 49.76 |
Book Value(Adj)-Unit Curr | 150.26 | 50.02 | 100.01 | 166.69 | 98.93 | 49.76 |